Donahoe PK - Search Results

1

Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression.

Clarke TR, Hoshiya Y, Yi SE, Liu X, Lyons KM, Donahoe PK. Clarke TR, et al. Among authors: donahoe pk. Mol Endocrinol. 2001 Jun;15(6):946-59. doi: 10.1210/mend.15.6.0664. Mol Endocrinol. 2001. PMID: 11376113

2

Developmentally regulated polyadenylation of two discrete messenger ribonucleic acids for müllerian inhibiting substance.

Lee MM, Cate RL, Donahoe PK, Waneck GL. Lee MM, et al. Among authors: donahoe pk. Endocrinology. 1992 Feb;130(2):847-53. doi: 10.1210/endo.130.2.1346380. Endocrinology. 1992. PMID: 1346380

3

Human müllerian inhibiting substance: enhanced purification imparts biochemical stability and restores antiproliferative effects.

Ragin RC, Donahoe PK, Kenneally MK, Ahmad MF, MacLaughlin DT. Ragin RC, et al. Among authors: donahoe pk. Protein Expr Purif. 1992 Jun;3(3):236-45. doi: 10.1016/1046-5928(92)90020-w. Protein Expr Purif. 1992. PMID: 1392620

4

Identification of müllerian inhibiting substance specific binding in human cell lines.

MacLaughlin DT, Levin RK, Catlin EA, Taylor LA, Preffer FI, Donahoe PK. MacLaughlin DT, et al. Among authors: donahoe pk. Horm Metab Res. 1992 Dec;24(12):570-5. doi: 10.1055/s-2007-1003392. Horm Metab Res. 1992. PMID: 1478615

5

Effect of human recombinant mullerian inhibiting substance on isolated epithelial and mesenchymal cells during mullerian duct regression in the rat.

Tsuji M, Shima H, Yonemura CY, Brody J, Donahoe PK, Cunha GR. Tsuji M, et al. Among authors: donahoe pk. Endocrinology. 1992 Sep;131(3):1481-8. doi: 10.1210/endo.131.3.1505479. Endocrinology. 1992. PMID: 1505479

6

Mullerian inhibiting substance binding and uptake.

Catlin EA, Ezzell RM, Donahoe PK, Manganaro TF, Ebb RG, MacLaughlin DT. Catlin EA, et al. Among authors: donahoe pk. Dev Dyn. 1992 Apr;193(4):295-9. doi: 10.1002/aja.1001930402. Dev Dyn. 1992. PMID: 1511169 Free article.

7

The inhibitory effects of müllerian-inhibiting substance on epidermal growth factor induced proliferation and progesterone production of human granulosa-luteal cells.

Kim JH, Seibel MM, MacLaughlin DT, Donahoe PK, Ransil BJ, Hametz PA, Richards CJ. Kim JH, et al. Among authors: donahoe pk. J Clin Endocrinol Metab. 1992 Sep;75(3):911-7. doi: 10.1210/jcem.75.3.1517385. J Clin Endocrinol Metab. 1992. PMID: 1517385

8

Recombinant human mullerian inhibiting substance inhibits human ocular melanoma cell lines in vitro and in vivo.

Parry RL, Chin TW, Epstein J, Hudson PL, Powell DM, Donahoe PK. Parry RL, et al. Among authors: donahoe pk. Cancer Res. 1992 Mar 1;52(5):1182-6. Cancer Res. 1992. PMID: 1531323

9

Isolation of the rat gene for Mullerian inhibiting substance.

Haqq C, Lee MM, Tizard R, Wysk M, DeMarinis J, Donahoe PK, Cate RL. Haqq C, et al. Among authors: donahoe pk. Genomics. 1992 Apr;12(4):665-9. doi: 10.1016/0888-7543(92)90291-y. Genomics. 1992. PMID: 1572639

10

Mullerian duct regression and antiproliferative bioactivities of mullerian inhibiting substance reside in its carboxy-terminal domain.

MacLaughlin DT, Hudson PL, Graciano AL, Kenneally MK, Ragin RC, Manganaro TF, Donahoe PK. MacLaughlin DT, et al. Among authors: donahoe pk. Endocrinology. 1992 Jul;131(1):291-6. doi: 10.1210/endo.131.1.1612008. Endocrinology. 1992. PMID: 1612008

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

343 results

Search Page

Filters